OFFICERS TRUE HEROES. MULTIPLE CONFIRMED CASES. AND I’M GOING TO LET THE DOCTOR HERE TAKE THIS WORD. BABESIOSIS IN MASSACHUSETTS, THAT’S A DISEASE PRIMARILY SPREAD BY DEER TICKS. SO WE TALK A LOT ...
60 Degrees Pharmaceuticals, Inc. announced the enrollment of the first patient in an expanded access study (NCT06478641) assessing the effectiveness of tafenoquine in treating patients with persistent ...
WASHINGTON, July 09, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (SXTP) (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), a pharmaceutical company focused on ...
All three patients enrolled in study have been cured, confirming high cure rate of tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publication Company calls for existing ...
WASHINGTON, July 19, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
You’ve heard of Lyme disease — now, infectious disease experts are warning of another serious tick-borne illness that’s on the rise: babesiosis. “If you live in areas where babesiosis is endemic, ...
Hosted on MSN
For severe babesiosis, red blood cell exchange is associated with markedly improved outcomes
A new study led by investigators from Mass General Brigham and Yale School of Public Health reveals that red blood cell exchange transfusion (ET) may provide critical benefits for patients ...
Jeremy Siegel: A rising tick population is causing a bump in cases of Lyme disease. But there’s another tick borne illness increasing across New England: Babesiosis. Joining us now for more is GBH’s ...
WASHINGTON, March 11, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"), a pharmaceutical company focused on developing new medicines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results